Chris Picardo
Chris Picardo is Partner at Madrona. Chris was Director of Finance and Business Intelligence at Rockets of Awesome and Private Equity Associate at The Invus Group, LLC. Chris is a Board Member at Aizen Therapeutics, Archon Biosciences and Terray Therapeutics, and a Board Observer at Vilya, Ovation, Knock and Unearth Technologies.
Concurrence CEO Ali Khokhar Explains How to Tell If a Healthcare Startup Is Too Early or the Wrong Bet
Ali Khokhar, Concurrence co-founder and CEO, discusses with Madrona Partner Sabrina Albert how to decide if a startup idea is too early or simply wrong, sharing lessons on timing, focus, trust, selling to skeptical buyers, and collecting new context while building a continuously learning system for patient outcomes.
UW PhD Student Zhihan Zhang Wins Madrona Prize for AI Agents That Shrink Models to Run on Tiny, Low‑Power Chips
A University of Washington team led by PhD student Zhihan Zhang won the Madrona Prize for an AI-agent system that automatically shrinks and tunes models to run on tiny, low-power chips, outperforming human experts within seven feedback rounds and open-sourcing their Embedded Arena benchmark.
Insurtech Faye raises $50M led by Madrona, bringing total funding to $100M as it scales AI and international growth
Faye, a Richmond-based travel insurance app, raised $50 million led by Madrona, bringing its total funding to $100 million since 2022 to scale AI, expand internationally, and improve claims and UX; the company reported millions of customers and $100 million in annualized revenue last year. Co-founder and CEO Elad Schaffer called the raise a shift from startup to scale-up as Faye pursues growth toward a possible future IPO.
See all 16 news stories about Chris Picardo.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
See all 15-
Madrona Partner, Investor 2017–2021 · current
-
Stealth Biotech Board Member 2024–present · current
-
Aizen Therapeutics Board Member 2024–present · current
Education
-
Williams College Bachelor of Arts (B.A.), Mathematics and English · 2009–2013